Skip to main content

ORIGINAL RESEARCH article

Front. Med.
Sec. Rheumatology
Volume 11 - 2024 | doi: 10.3389/fmed.2024.1446268
This article is part of the Research Topic Vascular Injury in Systemic Diseases: Current Concepts and Future Perspectives View all articles

Chronic low-grade inflammation in patients with systemic sclerosis is associated with increased risk for arteriosclerotic cardiovascular disease

Provisionally accepted
Ursula Heilmeier Ursula Heilmeier 1,2Daria Feldmann Daria Feldmann 2,3Andrew Leynes Andrew Leynes 4Magdalena Seng Magdalena Seng 5Ilona Jandova Ilona Jandova 2Marius Keute Marius Keute 6Florian Kollert Florian Kollert 2,7,8Reinhard E. Voll Reinhard E. Voll 2Stephanie Finzel Stephanie Finzel 2*
  • 1 Musculoskeletal Quantitative Imaging Research Group, University of California San Francisco, San Francisco, United States
  • 2 Department of Rheumatology and Clinical Immunology, Medical Center, University of Freiburg, Freiburg, Germany
  • 3 Department of Anesthesiology, Krankenhaus Porz am Rhein, Cologne, Germany
  • 4 Department of Radiology & Biomedical Imaging, University of California San Francisco, San Francisco, United States
  • 5 Department of Radiology and Nuclear Medicine, University Hospital Basel,, Basel, Switzerland
  • 6 Institute for Neuromodulation and Neurotechnology, University of Tübingen, Tübingen, Germany
  • 7 Department of Rheumatology and Immunology, University Hospital Bern, Bern, Switzerland
  • 8 Department of Rheumatology, University Hospital Basel, Basel, Switzerland

The final, formatted version of the article will be published soon.

    Please see final abstract version as submitted with the final revised and annotated manuscript.

    Keywords: systemic sclerosis, crp, arteriosclerotic cardiovascular risk, Carotid ultorasonography, inflammatory systemic sclerosis, Framingham score, ASCVD risk score, SCORE (systemic coronary risk evaluation)

    Received: 09 Jun 2024; Accepted: 14 Oct 2024.

    Copyright: © 2024 Heilmeier, Feldmann, Leynes, Seng, Jandova, Keute, Kollert, Voll and Finzel. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Stephanie Finzel, Department of Rheumatology and Clinical Immunology, Medical Center, University of Freiburg, Freiburg, Germany

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.